An fMRI Study of Opioid-related Changes in Neural Activity
NCT02818036
·
clinicaltrials.gov ↗
NA
Phase
COMPLETED
Status
82
Enrollment
OTHER
Sponsor class
Conditions
Social Acceptance
Interventions
DRUG:
Naltrexone
DRUG:
Placebo
Sponsor
Tristen Inagaki